The new model (LED BLU-U) in combination with LEVULAN KERASTICK (aminolevulinic acid HCl) topical solution, 20%, is indicated for the treatment of minimally to moderately thick actinic keratoses (AK) ...

The company announced that the USFDA has approved its enhanced PDT system through the agency’s Real-Time Review Program. This ...

The new device from Sun Pharma treats the disease in combination with LEVULAN® KERASTICK®, a liquid that contains a substance ...

"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next ...

Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. It often appears on sun-exposed areas such as the face, lips, ears, forearms, scalp, neck, decollete or ...

scalp, neck and back of the hands. If AK remains untreated, it can progress into squamous cell carcinoma. “Prevention is key to identifying and addressing actinic keratosis, including sun ...

With actinic keratosis (AK) diagnoses on the rise ... on areas of the body exposed to ultraviolet light, such as the scalp in the case of balding men, the face, forearms, neck, or back of the ...

Mumbai: Sun Pharmaceutical Industries Limited has announced that the U.S. Food and Drug Administration (FDA) has granted ...

Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. It often appears on sun-exposed areas such as the face, lips, ears, forearms, scalp, neck, decollete or back ...

that effectively targets and clears actinic keratosis (AK) on the face, scalp, arms and hands. LEVULAN KERASTICK (a topical 20% ALA [aminolevulinic acid] solution) + BLU-U blue light photodynamic ...

The initiative is a social media challenge ahead of Global AK Awareness Day, on May 24, which supports the work of The Skin Cancer Foundation and Euromelanoma The Hats On Challenge provides an ...